Rheumazentrum Ruhrgebiet, Ruhr-University Bochum, Herne, Germany.
Rheumatology Practice, Dortmund, Germany.
Rheumatology (Oxford). 2018 Sep 1;57(9):1541-1547. doi: 10.1093/rheumatology/kex318.
The Assessments of Spondyloarthritis international Society (ASAS) classification criteria for axial spondyloarthritis (axSpA) have been criticized because of insufficient differentiation towards FM. The aim of this study was to compare the performance of currently used classification criteria in patients diagnosed with axSpA or FM.
Patients were prospectively included if diagnosed with axSpA or FM by the treating rheumatologist and evaluated by an independent examiner for fulfilment of the classification criteria for axSpA (ASAS criteria) and/or FM (1990 ACR classification and 2010 ACR diagnostic criteria). Patients with axSpA were stratified based on classification as non-radiographic axSpA (nr-axSpA) or AS. Symptom severity was assessed by established disease-related questionnaires.
Overall, 300 patients were included, 100 with FM and 200 with axSpA of which 100 each had nr-axSpA and AS. Almost all FM patients fulfilled the 2010 (100%) and 1990 ACR criteria (98%) for FM, but only 2% fulfilled the ASAS criteria. When calculations were based on only the FM patients with available HLA-B27 results (n = 40), the proportion fulfilling the ASAS criteria was 5%. All axSpA patients met the ASAS criteria but also the 2010 (24%) and 1990 (13.5%) FM criteria. More patients with AS (29% and 19%) than with nr-axSpA (19% and 8%) fulfilled the 2010 and 1990 FM criteria, respectively.
FM patients only rarely fulfil classification criteria for axSpA but some axSpA patients also fulfil FM criteria. Since this was more frequent in patients with AS it may be related to the severity and duration of chronic pain in axSpA patients. Assessment instruments evaluated in axSpA are not disease-specific. The phenomenon of central pain sensitization in rheumatic diseases deserves more study.
评估强直性脊柱炎国际学会(ASAS)的中轴型脊柱关节炎(axSpA)分类标准因对纤维肌痛(FM)的区分不足而受到批评。本研究的目的是比较目前用于诊断为 axSpA 或 FM 的患者的分类标准的性能。
如果由治疗风湿病学家诊断为 axSpA 或 FM 的患者,并且由独立的检查者评估以满足 axSpA 的分类标准(ASAS 标准)和/或 FM(1990 年 ACR 分类和 2010 年 ACR 诊断标准),则前瞻性纳入患者。根据分类,将 axSpA 患者分为非放射学 axSpA(nr-axSpA)或 AS。通过既定的疾病相关问卷评估症状严重程度。
总共纳入 300 例患者,其中 100 例患有 FM,200 例患有 axSpA,其中 100 例分别患有 nr-axSpA 和 AS。几乎所有 FM 患者均符合 FM 的 2010 年(100%)和 1990 年 ACR 标准(98%),但只有 2%符合 ASAS 标准。当仅基于具有可用 HLA-B27 结果的 FM 患者进行计算(n = 40)时,符合 ASAS 标准的比例为 5%。所有 axSpA 患者均符合 ASAS 标准,但也符合 2010 年(24%)和 1990 年(13.5%)FM 标准。与 nr-axSpA(19%和 8%)相比,AS 患者(29%和 19%)更符合 2010 年和 1990 年 FM 标准。
FM 患者很少符合 axSpA 的分类标准,但一些 axSpA 患者也符合 FM 标准。由于这在 AS 患者中更为常见,因此可能与 axSpA 患者慢性疼痛的严重程度和持续时间有关。在 axSpA 中评估的评估工具不是疾病特异性的。风湿性疾病中中枢性疼痛敏化现象值得进一步研究。